Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological Indications.
Hunter E, Salter M, Powell R, Dring A, Naithani T, Chatziioannou ME, Gebregzabhar A, Issa M, Green J, Ng S, Lim CR, Keat CS, Suan AT, Raman R, Fatt HK, Luen FLW, Alshaker H, Pchejetski D, Blum D, Guiel T, Heaton R Jr, Levine J, Akoulitchev A.
Hunter E, et al. Among authors: pchejetski d.
Cancers (Basel). 2023 May 10;15(10):2696. doi: 10.3390/cancers15102696.
Cancers (Basel). 2023.
PMID: 37345033
Free PMC article.